Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
AstraZeneca
Genmab
Mayo Clinic
BioNTech SE
Neonc Technologies, Inc.
Ipsen
Children's Oncology Group
Arvinas Inc.
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Beijing Tide Pharmaceutical Co., Ltd
IDEAYA Biosciences
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Second Life Therapeutics
Linnaeus Therapeutics, Inc.
Inhibrx Biosciences, Inc
GV20 Therapeutics
DualityBio Inc.
Revolution Medicines, Inc.
GlaxoSmithKline
Vedanta Biosciences, Inc.
Eisai Inc.
7 Hills Pharma, LLC
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Cancer Research UK
NuCana plc
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Rapa Therapeutics LLC
Xynomic Pharmaceuticals, Inc.
Hangzhou Hanx Biopharmaceuticals, Ltd.
Sarcoma Oncology Research Center, LLC
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
GI Innovation, Inc.
Salubris Biotherapeutics Inc
NGM Biopharmaceuticals, Inc
Vector Vitale LLC
ENB Therapeutics, Inc
GeneMedicine Co., Ltd.
NextCure, Inc.
Rain Oncology Inc
Kineta Inc.
Western Sydney Local Health District